143 related articles for article (PubMed ID: 18045952)
1. Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion.
Neuwirt H; Puhr M; Cavarretta IT; Mitterberger M; Hobisch A; Culig Z
Endocr Relat Cancer; 2007 Dec; 14(4):1007-19. PubMed ID: 18045952
[TBL] [Abstract][Full Text] [Related]
2. [Androgens stimulate the expression of SOCS-3 and inhibits their effect on proliferation and secretion].
Neuwirt H; Puhr M; Cavarretta IT; Mitterberger M; Hobisch A; Culig Z
Aktuelle Urol; 2009 Aug; 40(4):231-4. PubMed ID: 19634073
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.
Neuwirt H; Puhr M; Santer FR; Susani M; Doppler W; Marcias G; Rauch V; Brugger M; Hobisch A; Kenner L; Culig Z
Am J Pathol; 2009 May; 174(5):1921-30. PubMed ID: 19342366
[TBL] [Abstract][Full Text] [Related]
4. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways.
Puhr M; Santer FR; Neuwirt H; Susani M; Nemeth JA; Hobisch A; Kenner L; Culig Z
Cancer Res; 2009 Sep; 69(18):7375-84. PubMed ID: 19738059
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer.
Bellezza I; Neuwirt H; Nemes C; Cavarretta IT; Puhr M; Steiner H; Minelli A; Bartsch G; Offner F; Hobisch A; Doppler W; Culig Z
Am J Pathol; 2006 Dec; 169(6):2199-208. PubMed ID: 17148681
[TBL] [Abstract][Full Text] [Related]
7. SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.
Puhr M; Santer FR; Neuwirt H; Marcias G; Hobisch A; Culig Z
Endocr Relat Cancer; 2010 Jun; 17(2):525-38. PubMed ID: 20335309
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of PLZF as a prostatic androgen-responsive gene.
Jiang F; Wang Z
Prostate; 2004 Jun; 59(4):426-35. PubMed ID: 15065091
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.
Hobisch A; Eder IE; Putz T; Horninger W; Bartsch G; Klocker H; Culig Z
Cancer Res; 1998 Oct; 58(20):4640-5. PubMed ID: 9788616
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the roles of suppressor of cytokine signaling-3 in prostate cancer development and progression.
Fu X; Ren L; Chen J; Liao K; Fu Y; Qian X; Xiao J
Asia Pac J Clin Oncol; 2015 Jun; 11(2):106-13. PubMed ID: 25899712
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.
Lin DL; Whitney MC; Yao Z; Keller ET
Clin Cancer Res; 2001 Jun; 7(6):1773-81. PubMed ID: 11410519
[TBL] [Abstract][Full Text] [Related]
13. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
14. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells.
Yu CR; Mahdi RM; Ebong S; Vistica BP; Gery I; Egwuagu CE
J Biol Chem; 2003 Aug; 278(32):29752-9. PubMed ID: 12783879
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
[TBL] [Abstract][Full Text] [Related]
17. SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells.
Horndasch M; Culig Z
Prostate; 2011 Sep; 71(12):1357-66. PubMed ID: 21308719
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
Alexander B; Fishman AI; Green D; Choudhury MS; Konno S
Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077
[TBL] [Abstract][Full Text] [Related]
19. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
[TBL] [Abstract][Full Text] [Related]
20. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
Kokontis JM; Hay N; Liao S
Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]